Prevalence of Peripheral Neuropathy Among Patients With Auditory Neuropathy
NCT06041360 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-09-18
Summary
Auditory neuropathy/ dys-synchrony/ peri-synaptic audiopathy (AN) are terms used to describe a specific hearing disorder with a disturbed auditory neural response in presence of normal cochlear function. Initially reported as early as the 1970s by ( Hinchcliffe et al) after observation of the patients with normal hearing thresholds, who had difficulty to detect the sounds especially in presence of background noise . Auditory Neuropathy is characterized by five integral features that distinguish it from other types of hearing loss. These are: Variable audiometric results anywhere from normal hearing to Sensorineural hearing loss of any degree up to profound hearing loss showing unusual audiometric pattern , Preserved outer hair cells (OHCs) responses such as otoacoustic emissions (OAEs) and/or cochlear microphonics (CM) , Altered neural processing such abnormal auditory brainstem responses (ABRs) with a reduced or absent wave V , Poor speech perception with poor speech recognition score that seems out of proportion compared to their pure-tone detection thresholds. , absent stapedial reflexes to the ipsilateral and contralateral tone at a 110-dB hearing level .
In 2008 it was found that AN does not represent a single disease entity but it is a heterogeneous disease category with a wide range of hearing loss types ,etiologies , age and clinical manifestations hence the adoption of the term auditory neuropathy spectrum disorder (ANSD) by an International Newborn Hearing Screening Conference held in Italy following a comprehensive study of newborn hearing test results.
The prevalence of ANSD is variable in published studies from (0.23 to 15%) among hearing impaired individuals . Regarding the underlying etiological factors, auditory neuropathy can be congenital or acquired . AN without the involvement of the neurological system has been termed as primary auditory neuropathy (PAN).
Peripheral neuropathy is not a constant finding in all patients with this hearing disorder , AN may occur in the afferent pathway of acoustic nerve, probably accompanied by the pathological changes of efferent nerve in the olivocochlear system inside the brainstem Our study is conducted to detect the prevalence of peripheral neuropathy among patients with auditory neuropathy spectrum disorder .
Conditions
- Auditory Neuropathy Spectrum Disorder,, Peripheral Neuropathy
Interventions
- DIAGNOSTIC_TEST
-
Pure tone audiometry PTA ,Speech audiometry ,Otoacoustic emission,Auditory evoked potentials including (ABR).
Neurological tests for diagnosis of peripheral neuropathy
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-04-01
- Completion
- 2024-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
NCT06278129 ·Status: RECRUITING
-
Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy
NCT06114680 ·Status: TERMINATED ·Phase: NA
-
Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
NCT03951584 ·Status: COMPLETED
-
The SeaSHeL National Prospective Cohort Study
NCT04108598 ·Status: UNKNOWN
-
Audio Vestibular Functions in COVID 19 Patients in Sohag Governate
NCT04860193 ·Status: COMPLETED
-
Intracochlear Injection of Glucocorticoid
NCT07134075 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Blood Markers in Adult Patients With Sudden Sensorineural Hearing Loss (SSNHL)
NCT03919474 ·Status: COMPLETED
-
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
NCT01621256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Clinical Study of HY01 in Patients
NCT04961099 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
NCT00802425 ·Status: COMPLETED ·Phase: PHASE2
-
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation
NCT00789061 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Audiovestibular Function in Infratentorial Superficial Siderosis
NCT04200664 ·Status: COMPLETED
-
Effect of Ultrasound-guided Stellate Ganglion Block Combined With Facial Nerve and Glossopharyngeal Nerve Block on the Treatment of Sudden Deafness
NCT05623384 ·Status: UNKNOWN ·Phase: NA
-
The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
NCT05403229 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
NCT07235488 ·Status: RECRUITING ·Phase: NA
-
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
NCT04601909 ·Status: COMPLETED ·Phase: PHASE1
-
'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss
NCT06997406 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
NCT03974867 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
NCT00335920 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
NCT06249919 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Sudden Hearing Loss Multi-center Clinical Trial
NCT02026479 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
NCT05776459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Autoimmunity in Inner Ear Disease
NCT00000361 ·Status: TERMINATED ·Phase: PHASE3
-
Hydrogen-oxygen Gas Mixture Inhalation in Patients With Sudden Sensorineural Hearing Loss
NCT04881435 ·Status: UNKNOWN ·Phase: NA
-
FX-322 in Adults With Acquired Sensorineural Hearing Loss
NCT05086276 ·Status: COMPLETED ·Phase: PHASE2